Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.
Business Model:
Revenue: $0
Employees: 1-10
Prism Pharmaceuticals was acquired by
Baxter International.
The acquisition happend on 2011-04-18.
Details of the transaction were not public
Address:
City: King Of Prussia
State: Pennsylvania
Zip:
Country: United States
Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in developing and commercializing cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was founded in 2004 and is based in King of Prussia, Pennsylvania.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2006 | Series B | 1 | $15M |
Essex Woodlands Healthcare Partners Essex Woodlands Healthcare Partners |
6/2013 | Series C | 1 | $15M |
Innovation Network Corporation of Japan Innovation Network Corporation of Japan |
1/2007 | Venture Round | 1 | - |
Stephens Group Stephens Group |
8/2005 | Series A | - | 1/2007 | Venture Round | 1 | - |
Stephens Group Stephens Group |
8/2005 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|